Table III.
Management and follow-up | Patients, n (%) |
---|---|
Perioperative chemo- and radiochemotherapies | |
Pre-operative therapies | 11 (14.6) |
Post-operative therapies | 24 (32.0) |
Follow-up period (months) | |
Mean | 14.3 |
Range | 0.2–51.7 |
Disease status | |
Remission | 60 (80.0) |
Alive with disease | 11 (14.7) |
Disease-associated death | 12 (16.0) |
Post-operative death (within 30 days) | 2 (2.7) |